Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Podravka d.d. Interim / Quarterly Report 2011

Oct 28, 2011

2084_10-q_2011-10-28_60880151-adc5-4212-b3bc-cfb67d480b2d.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Appendix 1
Reporting period:
01.01.2011.
do
30.09.2011.
Quarterly financial report of entrepreneur - TFI-POD
Registration number (MB)
03454088
Identification number of subject
010006549
Personal identification number
18928523252
(OIB)
Issueer company: PODRAVKA prehrambena industrija d.d., KOPRIVNICA
Postal code and place
48000
KOPRIVNICA
Street and number ANTE STARČEVIĆA 32
E-mail address: [email protected]
Internet adress: www.podravka.com
Code and name of comune/town
KOPRIVNICA
201
Code and county name
6
KOPRIVNIČKO-KRIŽEVAČKA Number of employees
6.695
Consolidated statement
Yes
(at quarter end)
NKD/NWC code:
1039
Subsidiaries subject to consolidation (according to IFRS): Registration number:
BELUPO d.d. Koprivnica 3805140
DANICA d.o.o. Koprivnica 0991279
ITAL-ICE d.o.o. Poreč 3746011
PODRAVKA POLSKA SP z.o.o. Kostrzyn, Poljska 5981449907
PODRAVKA LAGRIS a.s. Dolni Lhota u Luhačovic, Češka 3042510487
PODRAVKA SARAJEVO d.o.o. Sarajevo, BIH 20188537
Book keeping service:
Contact person: Celiščak Draga
(fill in only surname and name of contact person)
Phone number: 048 651 200 Fascimile: 048 651 805
E-mail address: [email protected]
Surname and name Vitković Miroslav
(authorised person for representation)
Disclosure documents:
shareholders' equity and notes to the financial statements
2. Statement of responsible persons for preparation of financial statements
3. Report of the Management Board on position of the Company
1. Financial statements (balance sheet, profit and loss account, cash flow statement, statement of changes in
PREHRAMBENA INDUSTRIVA d.d.
KOPRIVNICA
173
M.P. (signed by authorised person for representation)

$\mathcal{L}^{\text{max}}$

BALANCE SHEET
as at 30.09.2011.

Item Last year (net) Current year
(net)
1 $\overline{2}$ 3 4
ASSETS
A) RECEIVABLES FOR SUBSCRIBED BUT NOT PAID-IN CAPITAL 001
B) LONG-TERM ASSETS (003+010+020+029+033) 002 2.056.625.198 2.005.681.413
I. INTANGIBLE ASSETS (004 to 009) 003 352.332.661 354.679.451
1. Assets development 004 4.235.380 5.809.445
2. Concessions, patents, licences fees, trade and service marks, software and other rights 005 285.308.114 281.105.351
3. Goodwill 006 44.293.000 44.293.000
4. Prepayments for purchase of intangible assets 007 $\mathbf{0}$ $\mathbf 0$
5. Intangible assets in preparation 008 18,496,167 23.471.655
6. Other intangible assets 009 $\mathbf{0}$ $\Omega$
II. TANGIBLE ASSETS (011 to 019) 010 1.642.820.313 1.593.507.673
1. Land 011 176.061.299 175.072.182
2. Buildings 012 966.278.616 926.326.421
3. Plant and equipment 013 418.780.995 397.091.805
4. Tools, facility inventory and transport assets
5. Biological assets
014 23.292.232
0
21.671.308
6. Prepayments for tangible assets 015 5.361.777 7.108.338
7. Tangible assets in progress 016
017
49.188.929 62.392.358
8. Other tangible assets 018 3.856.465 3.845.261
9. Investments in buildings 019 $\mathbf{0}$ 0
III. LONG-TERM FINANCIAL ASSETS (021 to 028) 020 9.142.431 6,897,040
1. Investments (shares) with related parties 021 $\mathbf{0}$ 0
2. Loans given to related parties 022 $\mathbf{0}$ $\Omega$
3. Participating interest (shares) 023 330.000 330.000
4. Loans to entrepreneurs in whom the entity holds participating interests 024 $\mathbf{0}$ $\Omega$
5. Investments in securities 025 1.274.116 1.292.358
6. Loans, deposits and similar assets 026 7.538.295 5.274.682
7. Other long - term financial assets 027 20 0
8. Investments accounted by equity method 028 $\mathsf 0$ 0
IV. RECEIVABLES (030 to 032) 029 $\mathbf{0}$ $\overline{0}$
1. Receivables from related parties 030 $\mathbf 0$ 0
2. Receivables from based on trade loans 031 $\mathbf{0}$ $\mathbf 0$
3. Other receivables 032 $\Omega$
V. DEFERRED TAX ASSETS 033 52.329.793 50.597.249
C) SHORT TERM ASSETS (035+043+050+058) 034 1.933.337.889 1.984.791.318
I. INVENTORIES (036 to 042) 035 692.093.776 765.479.104
1. Raw-material and supplies 036 222.393.816 237.876.627
2. Work in progress 037 36.289.847 60.254.129
3. Finished goods 038 246.637.351 273.638.960
4. Merchandise 039 186.772.762 193.709.388
5. Prepayments for inventories 040 $\Omega$ $\mathbf 0$
6. Long - term assets held for sales 041 $\mathsf 0$ 0
7. Biological assets 042 $\Omega$ $\Omega$
II. RECEIVABLES (044 to 049) 043 991.603.792 1.026.643.761
1. Receivables from related parties 044 0
2. Accounts receivable 045 946.272.822 967.451.282
3. Receivables from participating parties 046 $\mathbf{0}$
4. Receivables from employees and members of related parties 047 2.518.619 1.899.858
5. Receivables from government and other institutions 048 34.687.811 38.605.967
6. Other receivables 049 8.124.540 18.686.654
III. SHORT TERM FINANCIAL ASSETS (051 to 057) 050 97.276.862 68.869.329
1. Shares (stocks) in related parties 051 0
2. Loans given to related parties 052 $\mathbf 0$ 0
3. Participating interests (shares) 053 $\mathbf 0$ 0
4. Loans to entrepreneurs in whom the entity holds participating interests 054 $\mathbf 0$ 0
5. Investments in securities
6. Loans, deposits, etc.
055 41.935.216 12.627.898
7. Other financial assets 056 46.170.596
9.171.050
46.808.920
9.432.511
IV. CASH AT BANK AND IN CASHIER 057
058
152.363.459 123.799.124
D) PREPAID EXPENSES AND ACCRUED REVENUE 059 18.226.022 20.200.850
E) TOTAL ASSETS (001+002+034+059) 060 4.008.189.109 4.010.673.581
F) OFF-BALANCE RECORDS 061 807.562.291 862.716.916
Item AOP
code
Last year (net) Current year
(net)
$\mathbf{1}$ $\overline{\mathbf{2}}$ 3 4
LIABILITIES AND CAPITAL
A) CAPITAL AND RESERVES (063+064+065+071+072+075+078) 062 1.634.817.706 1.722.764.904
I. SUBSCRIBED CAPITAL 063 1.626.000.900 1.626.000.900
II. CAPITAL RESERVES 064 22.337.176 22.337.176
III.RESERVES FROM PROFIT (066+067-068+069+070) 065 59.331.755 51.504.850
1. Reserves prescribed by low 066 19.785.012 20.727.012
2. Reserves for treasury shares 067 35.344.592 35.344.592
3. Treasury stocks and shares (deduction) 068 67.604.502 67.604.502
4. Statutory reserves 069 28.036.954 30.705.853
5. Other reserves 070 43.769.699 32.331.895
IV. REVALUATION RESERVES 071 0
V. RETAINED EARNINGS OR ACCUMULATED LOSS (073-074) 072 $-191.434.600$ $-111.803.316$
1. Retained earnings 073 $\mathbf 0$
2. Accumulated loss 074 191.434.600 111.803.316
VI. PROFIT/LOSS FOR THE CURRENT YEAR (076-077) 075 84.235.325 100.430.628
1. Profit for the current year 076 84.235.325 100.430.628
2. Loss for the current year 077 0
IX. MINORITY INTERESTS 078 34.347.150 34.294.666
B) PROVISIONS (080 to 082) 079 30.037.638 31.417.808
1. Provisions for pensions, severance pay, and similar liabilities 080 22.431.979 22.851.669
2. Reserves for tax liabilities 081 0
3. Other reserves 082 7.605.659 8.566.139
C) LONG - TERM LIABILITIES (084 to 092) 083 566.097.840 934.514.694
1. Liabilities to related parties 084 0 $\Omega$
2. Liabilities for loans, deposits etc. 085 0
3. Liabilities to banks and other financial institutions 086 558.956.840 928.458.694
4. Liabilities for received prepayments 087 0 0
5. Accounts payable 088 0 $\Omega$
6. Liabilities arising from debt securities 089 $\mathbf 0$ $\mathbf 0$
7. Liabilities to entrepreneurs in whom the entity holds participating interests 090 0 $\mathbf 0$
8. Other long-term liabilities 091 $\Omega$
9. Deferred tax liability 092 7.141.000 6.056.000
D) SHORT - TERM LIABILITIES (094 to 105) 093 1.682.185.308 1.216.119.897
1. Liabilities to related parties 094 $\mathbf 0$
2. Liabilities for loans, deposits etc. 095 12.068 412.061
3. Liabilities to banks and other financial institutions 096 472.129.696 461.843.306
4. Liabilities for received prepayments 097 2.705.585 988,889
5. Accounts payable 098 496.474.625 539.077.364
6. Liabilities arising from debt securities 099 507.084.963 5.837.867
7. Liabilities to entrepreneurs in whom the entity holds participating interests 100 0 0
8. Liabilities to employees 101 61.340.528 59.355.642
9. Liabilities for taxes, contributions and similar fees 102 13.024.738 14.699.857
10. Liabilities to share - holders 103 686.698 684.699
11. Liabilities for long-term assets held for sale 104
12. Other short - term liabilities 105 128.726.407 133.220.212
E) DEFFERED SETTLEMENTS OF CHARGES AND INCOME DEFERRED TO FUTURE PERIOD 106 95.050.617 105.856.278
F) TOTAL - CAPITAL AND LIABILITIES (062+079+083+093+106) 107 4.008.189.109 4.010.673.581
G) OFF-BALANCE RECORDS 108 807.562.291 862.716.916
APPENDIX to balance sheet(to be filled in by entrepreneur that prepares consolidated annual financial report)
CAPITAL AND RESERVES
1. Attributed to equity holders of parent company 109 1.600.470.556 1.688.470.238
2. Attributed to minority interest 110 34.347.150 34.294.666
PROFIT AND LOSS ACCOUNT
for the period 01.01.2011. do 30.09.2011.
Item AOP
code
Last year Current year
Comulative Quartely Comulative Quartely
$\mathbf{1}$ $\overline{2}$ 3 4 5 6
I. OPERATING REVENUE (112+113) 111 2.647.757.925 934.661.534 2.756.300.236 968.545.337
1. Sales revenue 112 2.593.831.264 931.093.302 2.690.290.194 966.119.459
2. Other operating revenues 113 53.926.661 3.568.232 66.010.042 2.425.878
II. OPERATING EXPENSES (115+116+120+124+125+126+129+130) 114 2.455.699.178 848.532.741 2.560.994.837 876.121.351
1. Changes in value of work in progress and finished products 115 $-43.828.455$ $-36.282.149$ $-50.667.769$ $-33.235.428$
2. Material costs (117 to 119) 116 1.649.557.904 607.223.479 1.762.990.727 632.312.604
a) Raw material and material costs 117 895.143.147 341.357.601 965.635.616 353.947.343
b) Costs of goods sold 118 350.504.286 131.508.552 388,361.750 136.404.511
c) Other external costs 119 403.910.471 134.357.326 408.993.361 141,960,750
3. Staff costs (121 to 123) 120 550.788.476 184.285.984 542.924.919 181.680.165
a) Net salaries and wages 121 370.216.215 116.178.148 366.725.666 114.446.902
b) Cost for taxes and contributions from salaries 122 114.986.296 43.138.085 111.641.338 42.557.681
c) Contributions on gross salaries 123 65.585.965 24.969.751 64.557.915 24.675.582
4. Depreciation 124 116.636.938 38.908.736 117.961.616 39.080.070
5. Other costs 125 132.555.173 43.454.496 142.524.544 44.741.198
6. Impairment (127+128) 126 21.512.304 5.258.865 11.113.916 4.589.101
a) Impairment of long-term assets (financial assets excluded) 127 $\Omega$ 0 $\Omega$
b) Impairment of short - term assets (financial assets excluded) 128 21.512.304 5.258.865 11.113.916 4.589.101
7. Provisions 129 432.502 354.307 673.308 400.478
8. Other operating costs 130 28.044.336 5.329.023 33.473.576 6.553.163
III. FINANCIAL INCOME (132 to 136) 131 31.921.032 37.181 33.536.422 7.427.890
1. Interest income, foreign exchange gains, dividends and similar income from related 132 $\Omega$ $\Omega$
2. Interest income, foreign exchange gains, dividends and similar income from non - 133 31.891.640 2.063.212 32.537.169 9.088.845
3. Share in income from affiliated entrepreneurs and participating interests 134 $\Omega$ $\Omega$ $\Omega$
4. Unrealized gains (income) from financial assets 135 29.392 $-2.026.031$ 999.253 $-1.660.955$
5. Other financial income 136 $\Omega$ $\circ$ $\circ$
IV. FINANCIAL EXPENSES (138 do 141) 137 130.480.449 32.486.160 110,291.007 48.251.569
1. Interest expenses, foreign exchange losses, dividends and similar expenses from related 138 $\Omega$ 0 $\Omega$
2. Interest expenses, foreign exchange losses, dividends and similar expenses from non - 139 97.893.122 27.792.342 103.674.366 45.458.894
3. Unrealized losses (expenses) on financial assets 140 32.587.327 4.693.818 6.616.641 2.792.675
4. Other financial expenses 141 0 $\mathbf{0}$ $\circ$
V. INCOME FROM INVESTMENT - SHARE IN PROFIT OF ASSOCIATED ENTREPRENEURS 142 $\Omega$ $\circ$ $\circ$
VI. LOSS FROM INVESTMENT - SHARE IN LOSS OF ASSOCIATED ENTREPRENEURS 143 $\mathbf 0$ 0 $\Omega$
VII. EXTRAORDINARY - OTHER INCOME 144 $\mathbf 0$ $\mathbf{O}$ $\circ$
VIII. EXTRAORDINARY - OTHER EXPENSES 145 $\Omega$ $\mathbf{0}$ $\Omega$
IX. TOTAL INCOME (111+131+142 + 144) 146 2.679.678.957 934.698.715 2.789.836.658 975.973.227
X. TOTAL EXPENSES (114+137+143 + 145) 147 2.586.179.627 881.018.901 2.671.285.844 924.372.920
XI. PROFIT OR LOSS BEFORE TAXATION (146-147) 148 93.499.330 53.679.814 118.550.814 51.600.307
1. Profit before taxation (146-147) 149 93.499.330 53.679.814 118.550.814 51.600.307
2. Loss before taxation (147-146) 150 $\Omega$ $\Omega$ $\circ$
XII. PROFIT TAX 151 11.315.880 2.983.756 18.382.186 6.846.637
XIII. PROFIT OR LOSS FOR THE PERIOD (148-151) 152 82.183.450 50.696.058 100.168.628 44.753.670
1. Profit for the period (149-151) 153 82.183.450 50,696.058 100.168.628 44.753.670
2. Loss for the period (151-148) 154 O 0 $\circ$
APPENDIX to P&L account (to be filled in by entrepreneur that prepares consolidated financial report)
XIV. PROFIT OR LOSS FOR THE PERIOD
1. Attributed to equity holders of parent company 155 82.305.450 51.147.143 100.430.628 44.863.753
2. Attributed to minority interest 156 $-122.000$ $-451.085$ $-262.000$ $-110.083$
STATEMENT OF OTHER COMPREHENSIVE INCOME (IFRS)
I. PROFIT OR LOSS FOR THE PERIOD (= 152) 157 82.183.450 50,696.058 100.168.628 44.753.670
III. OTHER COMPREHENSIVE INCOME / LOSS BEFORE TAX (159 do 165) 158 8.424.253 $-453.194$ $-11.228.984$ $-10.156.596$
1. Exchange differences on translation of foreign operations 159 8.424.253 $-453.194$ $-11.228.984$ $-10.156.596$
2. Movements in revaluation reserves of long - term tangible and intangible assets 160
3. Profit or loss from reevaluation of financial assets available for sale 161
4. Gains or losses on efficient cash flow hedging 162
5. Gains or losses on efficient hedge of a net investment in foreign countries 163
6. Share in other comprehensive income / loss of associated companies 164
7. Actuarial gains / losses on defined benefit plans 165
III. TAX ON OTHER COMPREHENSIVE INCOME FOR THE PERIOD 166
IV. NET OTHER COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (158-166) $-453.194$ $-11.228.984$
167 8.424.253 $-10.156.596$
V. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (157+167) 168 90.607.703 50.242.864 88.939.644 34.597.074
APPENDIX to Statement of other comprenhensive income (to be filled in by entrepreneur that prepares consolidated financial report)
VI. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD
1. Attributed to equity holders of parent company 169 90.744.910 50.519.223 88.992.128 34.473.253
2. Attributed to minority interest 170 $-137.207$ $-276.359$ $-52.484$ 123.821

STATEMENT OF CASH FLOWS - INDIRECT METHOD
for the period 01.01.2011. do 30.09.2011.

T.

Item AOP
code
Last year Current year
1 $\overline{2}$ 3 4
CASH FLOW FROM OPERATING ACTIVITIES
1. Profit before tax 001 93.499.363 118.550.815
2. Depreciation 002 116.636.939 117.961.616
3. Increase in short term liabilities 003 51.390.636
4. Decrease in short term receivables 004 81.640.104
5. Decrease in inventories 005
6. Other increase in cash flow 006 22.850.801 24.272.384
I. Total increase in cash flow from operating activities (001 to 006) 007 314.627.207 312.175.451
1. Decrease in short term liabilities 008 123.626.000
2. Increase in short term receivables 009 27.974.719
3. Increase in inventories 010 51.531.812 72.939.104
4. Other decrease in cash flow 011 32.375.000
II. Total decrease in cash flow from operating activities (008 to 011) 012 175.157.812 133.288.823
A1) NET INCREASE IN CASH FLOW FROM OPERATING ACTIVITIES 013 139.469.395 178.886.628
A2) NET DECREASE IN IN CASH FLOW FROM OPERATING ACTIVITIES 014 0
CASH FLOW FROM INVESTING ACTIVITIES
1. Cash inflows from sales of long-term tangible and intangible assets 015 6,546,000 2.448.000
2. Cash inflows from sales of equity and debt instruments 016 14.875.000 11.354.000
3. Interests receipts 017 7.502.000 5.147.158
4. Dividend receipts 018
5. Other cash inflows from investing activities 019 1.402.000 2.466.000
III. Total cash inflows from investing activities (015 to 019) 020 30.325.000 21.415.158
1. Cash outflow for purchase of long-term tangible and intangible assets 021 63.325.000 68.476.400
2. Cash outflow for acquisition of equity and debt financial instruments 022 2.001.000
3. Other cash outflow for investing activities 023 1.219.000 4.861.000
IV. Total cash outflow for investing activities (021 do 023) 024 64.544.000 75.338.400
B1) NET INCREASE IN CASH FLOW FROM INVESTING ACTIVITIES (020-024) 025 0
B2) NET DECREASE IN CASH FLOW FROM INVESTING ACTIVITIES 026 34.219.000 53.923.242
CASH FLOW FROM FINANCIAL ACTIVITIES
1. Cash inflow from issuing property and debt financial instruments 027
2. Proceeds from the credit principal, promissory notes, borrowings and other loans 028 433.781.000 606.707.000
3. Other proceeds from financial activities 029
V. Total cash inflows from financial activities (027 to 029) 030 433.781.000 606.707.000
1. Cash outflow for repayment of credit principal and bonds 031 526.898.000 757.293.000
2. Cash outflow for dividends paid 032
3. Cash outflow for financial lease 033 3.226,000 2.941.000
4. Cash outflow for purchase of treasury shares 034
5. Other cash outflow for financial activities 035
VI. Total cash outflow for financial activities (031 to 035) 036 530.124.000 760.234.000
C1) NET INCREASE IN CASH FLOW FROM FINANCIAL ACTIVITIES 037 0
C2) NET DECREASE IN CASH FLOW FROM FINANCIAL ACTIVITIES 038 96.343.000 153.527.000
Total increase in cash flow $(013 - 014 + 025 - 026 + 037 - 038)$
Total decrease in cash flow (014 - 013 + 026 - 025 + 038 - 037) 039
040
8.907.395
0
28.563.614
Cash and cash equivalents at the beginning of the period 041 145.269.000
Increase of cash and cash equivalents 042 152.362.738
8.907.395
Decrease of cash and cash equivalents 043 28.563.614
Cash and cash equivalents at the end of the period 044 154.176.395 123.799.124

STATEMENT OF CHANGES IN EQUITY for the period 01.01.2011 do 30.09.2011

Item AOP
code
Last year Current year
1 $\overline{2}$ 3 4
1. Subscribed capital 001 1.626.000.900 1.626.000.900
2. Capital reserves 002 22.337.176 22.337.176
3. Reserves from profit 003 59.331.755 51.504.850
4. Retained earnings or accumulated loss 004 $-191.434.600$ $-111.803.316$
5. Profit or loss for the current year 005 84.235.325 100.430.628
6. Revaluation of long - term tangible assets 006
7. Revaluation of intangible assets 007
8. Revaluation of financial assets available for sale 008
9. Other revaluation 009 34.347.150 34.294.666
10. Total capital and reserves (AOP 001 do 009) 010 1.634.817.706 1.722.764.904
11. Currency gains and losses arising from net investement in foreign operations 011 13,374,000 $-11.438.500$
12. Current and deferred taxes (part) 012
13. Cash flow hedging 013
14. Changes in accounting policy 014
15. Correction of significant errors in prior period 015
16. Other changes of capital 016 82.347.715 99.385.698
17. Total increase or decrease in capital (AOP 011 do 016) 017 95.721.715 87.947.198
17 a. Attributed to equity holders of parent company 018 95.735.715 87.999.682
17 b. Attributed to minority interest 019 $-14.000$ $-52.484$

Notes

Main business characteristics and significant events in 2011

    1. The total sales of the Podravka Group in the first nine months of the year 2011 amounted to 2,690.3 million HRK, which represents a sales growth of 4% compared to the same period of the year before. Sales of the Strategic Business Area (SBA) Food and Beverages totalled 2,132.2 million HRK, which represented a sales growth of 3%, while the sales of the SBA Pharmaceuticals was 558.1 million HRK, which is an 8% sales increase.
    1. The operating profit (EBIT) of the Podravka Group increased by 21% and amounted to 193.5 million HRK, while the operating margin (EBIT margin) is 7.2%.
    1. The realised net profit of the Podravka Group is 100.4 million HRK, which represents a 22% increase, while the net margin is 3.7%.
    1. The total value of capital investments in the observed period amounted to 68.5 million HRK.
    1. The General Assembly of Podravka d.d. was held on 14 July 2011 where it was decided that last year's net profit in the amount of 10.9 million HRK would be distributed for the coverage of the loss brought forward from previous years. Apart from this, resolutions were passed on the amendments to the Articles of Association of Podravka d.d. and members of the Management and Supervisory Boards were discharged, accordingly.
    1. A total of 576,880 shares of Podravka d.d. in the ownership of FIMA AMI Ltd. was sold on 19 July 2011. The average price in the transaction was 312.87 HRK, and the buyers were from mandatory pension funds (75.57%), voluntary pension funds (4.27%) and other domestic funds (17.44%), insurances (1.59%) and foreign investors (1.13%).

The accounting policy in 2011 year did not change.

Koprivnica, 28 October 2011

INTERIM MANAGEMENT REPORT ON THE ACHIEVED BUSINESS RESULTS OF THE PODRAVKA GROUP FOR JANUARY - SEPTEMBER 2011 AND THE THIRD QUARTER OF THE YEAR 2011

In the period from January to September 2011 the Podravka Group achieved operating income in the amount of 2,756 million HRK, which is a 4% increase compared to the same period of the vear before.

Sales revenue of the Podravka Group amounted to 2,690.3 million HRK and are 4% higher compared to the same period of the year 2010.

Sales of the SBA Food and Beverages totalled 2,132.2 million HRK, which is a 3% sales growth compared to the same period of the year 2010. This growth was a result of a higher level of sales on foreign markets (5%), and the foreign markets which have recorded an increase of sales of the SBA Food and Beverages are South-East Europe (7%), with the most prominent markets of Bosnia and Herzegovina (6%), Serbia (14%) and Slovenia (4%), then Central Europe (6%) with the Czech Republic (16%) and Poland (4%) followed by Western Europe, overseas countries and Orient (3%), where Austria (59%) and Australia (14%) recorded the highest growth.

The SBA Pharmaceuticals achieved sales in the amount of 558.1 million HRK, which is a sales growth of 8% compared to the same period of the year 2010. Sales growth of the SBA Pharmaceuticals was mostly generated by the 16% growth on foreign markets with the highest contribution coming from the markets of Russia (26%), Bosnia and Herzegovina (10%), Slovenia (41%) and Turkey (114%). Sales on the domestic market in the observed period also grew (3%) based on a higher level of sales of prescription drugs (3%) and increased sales of the OTC programme (1%). According to the ATC classification, product groups which achieved the most significant growth are drugs with effect on the nervous system (12%) and drugs for infection system treatment (16%).

The total operating costs/expenses amounted to 2,561 million HRK and have increased by 4.3%. Material costs cover 69% of operating costs/expenses and have increased by 6.9% compared to same period of the year before. The increase of material costs was primarily influenced by higher costs of raw material and material and higher incoming prices.

Staff costs (21.2%) with a decrease of 1.4% also hold a significant share in the structure of operating costs/expenses.

PODRAVKA Inc, Koprivnica, Ante Starčevića 32, The Commercial Court Varaždin, MBS: 010006549, PIN: 18928523252, foundation capital: 1.626.000.900,00 kunas, paid in full, total number of shares issued: 5.420.003, nominal share value: 300.00 kunas, Privredna banka Zagreb d. d.. Zagreb, Račkoga 6, bank account: 2340009-1100098526, president of the Supervisory Board: Lj. Jurčić, president of the Management Board M. Vitković,

members of the Management Board K. Bešvir, L. Kljajić, M. Pucar, M. Repić

COMPANY MANAGEMENT

The realised net profit is 100.4 million HRK and is 22% higher than the realised net profit of the same period the year before. The recovery of insurance funds within the SBA Pharmaceuticals in the amount of 23.7 million HRK had significant effect on the realised net profit.

Operating income in the amount of 968.5 million HRK was realised in the third quarter of which 966 million HRK refers to sales revenue, which increased by 4% compared to the same quarter of last year.

Operating costs/expenses in the third quarter amounted to 876.1 million HRK and have increased by 3% compared to the same period of the year before.

The realised net profit of the third quarter is 44.8 million HRK.

The total value of assets of the Podravka Group as of 30 September 2011 is 4,011 million HRK and remains almost unchanged compared to the year end balance of 2010. The structure of assets has changed as the value of non-current assets decreased by 50.9 million HRK, while at the same time current assets increased by 51.4 million HRK.

Inventories (73.4 million HRK) and receivables (35.0 million HRK) have increased within the structure of current assets. Short-term financial assets have been reduced by 28.4 million HRK as well as the balance of cash and cash equivalents by 28.6 million HRK compared to the year end of 2010.

The total indebtedness of the Podravka Group in the period from January to September of the current year has been reduced by 131.2 million HRK (from 1.511 million HRK as of 31 December 2010 to 1,380 million HRK as of 30 September 2011). The net debt amounts to 1,256 million HRK.

President of the Mana $\phi$ ement Board:

COMPANY MANAGEMENT

Koprivnica, 28, October 2011

STATEMENT FROM EXECUTIVES RESPONSIBLE FOR PREPARING FINANCIAL STATEMENTS

Consolidated and unaudited financial statements of the Podravka Group for the period January -September 2011 have been prepared in compliance with the Accounting Act of the Republic of Croatia and International Financial Reporting Standards (IFRS) and provide an overall and true presentation of assets, liabilities, profit and loss, financial position and business operations of the Group and all related companies involved in the consolidation.

During the observed period, there were no changes in accounting policies of the Podravka Group.

Accounting Director: Draga Celiščak Chricall Do

Board Member for Finance: Lidija Kljajić